Clinical Trial Update: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating arzoxifene hydrochloride as hormone therapy for women with recurrent, advanced, or metastatic endometrial cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Arzoxifene hydrochloride (arzoxifene hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED